Rx Imola
by Randox Laboratories Limited 510(k)
Active
510(k) K052914
Regulatory status
Recall ongoing. 1 ongoing FDA recall. See recalls
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK052914 | Date31 Mar 2006 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Ongoing Z-0200-2024
RX Parameter rerun settings (Sample Volume Low/High), and Dilutions used for Auto reruns, not meeting sample re-run conditions when samples are above or below assay range and may result i issues with the re-run feature conditions when incorrectly. Potential to report incorrectly.
-
- Terminated Z-2084-2019
There was a report of a malfunction with the sensor which resulted in an increase of temperature leading to melting of internal wires and scorch damage to the internal structure of the instrument.
-
- Terminated Z-2059-2018
Abnormal premature termination of the software could affect the use of the analyser when running patient samples. The impact being a delay in reporting test results.
-
- Terminated Z-0725-2017
According to the firm, Carry over was observed when the amylase or pancreatic amylase test is run directly before or after the Magnesium assay. An update is required to the RX Imola analyser running order and an acid wash recommended when setting up the magnesium assay. A correction was made to the IFU for the Magnesium assay and all RX Imola customers in the USA were contacted with the updated instruction.
Specification
- 510(k) Number
- FDA Product Code
- CEM
- FDA applicant
- Randox Laboratories, Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1600
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent